share_log

先瑞达医疗-B(06669):冠状动脉高压球囊扩张导管翼延的注册申请获中国国家药品监督管理局批准

Xianruida Medical-B (06669): Application for registration of coronary hypertension balloon dilatation catheter pterygium was approved by China Drug Administration

Zhitong Finance ·  Mar 26 07:23

Xianruida Medical-B (06669) issued an announcement. On March 20, 2024, the Group received China's national pharmaceuticals...

Zhitong Finance App News, Xianruida Medical-B (06669) issued an announcement. On March 20, 2024, the Group received registration approval from the China National Drug Administration for coronary hypertension balloon dilatation catheter wings. Pterygium is suitable for dilating coronary artery stenosis or coronary artery bypass vascular stenosis to improve myocardial perfusion. The company will launch marketing activities in the Chinese market in due course.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment